SUSW:LSE:LSE-iShares MSCI World SRI UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 10.015

Change

-0.09 (-0.84)%

Market Cap

N/A

Volume

0.42M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+0.60 (+0.35%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.44%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.24 (+1.36%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-1.62 (-1.60%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.35 (+1.85%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.45 (+1.49%)

USD 259.48B
0QZO:LSE 0QZO

+1.10 (+1.30%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+0.80 (+0.59%)

USD 202.26B
0R24:LSE Intel Corp.

+0.92 (+4.93%)

USD 196.14B

ETFs Containing SUSW:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.09% 14% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.09% 14% F 21% F
Trailing 12 Months  
Capital Gain -4.16% 26% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.16% 25% F 39% F
Trailing 5 Years  
Capital Gain 64.28% 64% D 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.28% 61% D- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.18% 76% C+ 76% C+
Dividend Return 13.18% 75% C 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.08% 51% F 70% C-
Risk Adjusted Return 100.75% 88% B+ 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike